Market Access Strategy for Medical Devices in Europe
Strategic recommendations on the topic of market access pathways for medical devices and IVD tests
Recent news and posts
An agreement reached in financing negotiations: almost three percent more for outpatient care in 2026 in Germany
On September 17, 2025, the National Association of Statutory Health Insurance Physicians (KBV) and the National Association of Statutory Health Insurance Funds (GKV-Spitzenverband) announced that they had reached an agreement in financing negotiations concerning outpatient care.
As a result, the financial resources for outpatient care will increase by almost 2.8% in 2026. Thus, the tariffs for all medical and psychotherapeutic services in the German Uniform Evaluation Standard (EBM) catalog will increase by 2.8% on January 1, 2026.
In total, sickness funds are expected to spend around €52 billion on the medical treatment of their insured persons in outpatient care in 2026.
The full details in German can be found here and here.
The AOTMiT is a consultative and advisory entity supervised by the Minister of Health (MoH). The role of the Agency is to assist the MoH in the decision-making process regarding the financing of medicines and medical technologies in the healthcare system.
This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.